Literature DB >> 12144862

Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat.

W R Zhang1, K Sato, M Iwai, I Nagano, Y Manabe, K Abe.   

Abstract

The time dependent influence of adenovirus-mediated glial cell line-derived neurotrophic factor (GDNF) gene (Ad-GDNF) was examined after 90 min of transient middle cerebral artery occlusion (MCAO) in rats. Treatment with Ad-GDNF significantly reduced the infarct volume when immediately administered after the reperfusion, but became insignificant when administered at 1 h after the reperfusion as were the cases treated with vehicle- and adenoviral vector containing the E. coli lacZ gene (Ad-LacZ)-treated groups. The protective effect of GDNF was related to the significant reduction of the number of TUNEL positive cells as well as immunohistochemical positive cells for active caspase-3 but not -9. These results showed that exogenous GDNF gene transfer successfully reduced the infarct size in a time-dependant manner by suppressing active caspase-3 but not active caspase-9. However, the therapeutic time window was shorter than the effect of GDNF protein itself previously reported.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144862     DOI: 10.1016/s0006-8993(02)02923-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

Review 1.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Combining glial cell line-derived neurotrophic factor gene delivery (AdGDNF) with L-arginine decreases contusion size but not behavioral deficits after traumatic brain injury.

Authors:  M L Degeorge; D Marlowe; E Werner; K E Soderstrom; M Stock; A Mueller; M C Bohn; D A Kozlowski
Journal:  Brain Res       Date:  2011-06-02       Impact factor: 3.252

Review 3.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

4.  Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.

Authors:  Yoshifumi Horita; Osamu Honmou; Kuniaki Harada; Kiyohiro Houkin; Hirofumi Hamada; Jeffery D Kocsis
Journal:  J Neurosci Res       Date:  2006-11-15       Impact factor: 4.164

5.  Mesencephalic astrocyte-derived neurotrophic factor reduces ischemic brain injury and promotes behavioral recovery in rats.

Authors:  Mikko Airavaara; Hui Shen; Chi-Chung Kuo; Johan Peränen; Mart Saarma; Barry Hoffer; Yun Wang
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

Review 6.  New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies.

Authors:  Chiara Cossetti; Clara Alfaro-Cervello; Matteo Donegà; Giulia Tyzack; Stefano Pluchino
Journal:  Cell Tissue Res       Date:  2012-02-10       Impact factor: 5.249

7.  Trophic factors and stem cells for promoting recovery in stroke.

Authors:  Guven Uzun; Dawood Subhani; Srikureja Amor
Journal:  J Vasc Interv Neurol       Date:  2010-01

Review 8.  Growth factors in ischemic stroke.

Authors:  S Lanfranconi; F Locatelli; S Corti; L Candelise; G P Comi; P L Baron; S Strazzer; N Bresolin; A Bersano
Journal:  J Cell Mol Med       Date:  2009-12-08       Impact factor: 5.310

Review 9.  Evaluation of Gene Therapy as an Intervention Strategy to Treat Brain Injury from Stroke.

Authors:  Amanda J Craig; Gary D Housley
Journal:  Front Mol Neurosci       Date:  2016-05-24       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.